Cleared Traditional

K051677 - OPTIGEN ALLERGEN SPECIFIC IGE ASSAY

K051677 is an FDA 510(k) clearance for OPTIGEN ALLERGEN SPECIFIC IGE ASSAY, manufactured by Hitachi Chemical Diagnostics, Inc.. The device is a Class 2 Immunology device with product code DHB cleared through the Traditional 510(k) pathway after a 216-day FDA review.

K051677 · Hitachi Chemical Diagnostics, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2006
Decision
216d
Days
Class 2
Risk

K051677 is an FDA 510(k) clearance for the OPTIGEN ALLERGEN SPECIFIC IGE ASSAY. Classified as System, Test, Radioallergosorbent (rast) Immunological (product code DHB), Class II - Special Controls.

Submitted by Hitachi Chemical Diagnostics, Inc. (Mountain View, US). The FDA issued a Cleared decision on January 23, 2006 after a review of 216 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5750 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hitachi Chemical Diagnostics, Inc. devices

FDA 510(k) Submission Details - K051677

510(k) Number K051677 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 2005
Decision Date January 23, 2006
Days to Decision 216 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
112d slower than avg
Panel avg: 104d · This submission: 216d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHB Device Classification - Class 2, Special Controls

Product Code DHB System, Test, Radioallergosorbent (rast) Immunological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHB System, Test, Radioallergosorbent (rast) Immunological

All 215
Devices cleared under the same product code (DHB) and FDA review panel - the closest regulatory comparables to K051677.
HY-TEC SPECIFIC AND TOTAL IGE EIA SYSTEM
K081217 · Hycor Biomedical, Inc. · May 2008
HY*TEC EXTENDED SPECIFIC IGE EIA, MCS ASSAY USING TECAN FREEDOM EVO RSP 200
K080322 · Hycor Biomedical, Inc. · Mar 2008
IMMUNOCAP ALLERGEN F338, SCALLOP WITH MODEL(S): 14-4895-01
K071913 · Phadia AB · Aug 2007
IMMULITE 2000 ALLERGEN-SPECIFIC IGE
K023152 · Diagnostic Products Corp. · Dec 2002
IMMULITE 2000 SPECIFIC ALLERGENS
K021206 · Diagnostic Products Corp. · May 2002
IMMULITE 2000 MIXED ALLERGEN PANELS
K021208 · Diagnostic Products Corp. · May 2002